Effective antihypertensive therapy: focus on adherence management
https://doi.org/10.15829/1728-8800-2020-2663
Abstract
High medical adherence is a prerequisite for achieving goals in the treatment of hypertension (HTN). The majority of patients with HTN showed low adherence to treatment, which requires finding ways to solve this problem. This review describes the factors influencing adherence, ways of its assessment, and analyzes methods of increasing medical adherence in hypertensive patients. Noteworthy is the lack of publications describing the effectiveness of methods for increasing long-term (>2 years) adherence in hypertensive patients. The review also describes a not fully clear individualized approach, which consists in choosing a therapy regimen based on levels of medical adherence, medical follow-up and lifestyle modification.
About the Authors
S. S. Bunova
National Research University Belgorod State University (BelSU))
Russian Federation
Svetlana Sergeevna Bunova - Department of family medicine, Professor of the Department
Russian Federation
Svetlana Sergeevna Bunova - Department of family medicine, Professor of the Department
N. I. Zhernakova
National Research University Belgorod State University (BelSU))
Russian Federation
Nina Ivanovna Zhernakova - Department of family medicine, head of the Department
Russian Federation
Nina Ivanovna Zhernakova - Department of family medicine, head of the Department
M. M. Fedorin
Omsk State Medical University
Russian Federation
Maksim Mikhailovich Fedorin - The inspector of Department of development of regional health and medical activity
Russian Federation
Maksim Mikhailovich Fedorin - The inspector of Department of development of regional health and medical activity
Y. P. Skirdenko
Omsk State Medical University
Russian Federation
Yuliya Petrovna Skirdenko - Assistant of the Department of faculty therapy and gastroenterology
Russian Federation
Yuliya Petrovna Skirdenko - Assistant of the Department of faculty therapy and gastroenterology
O. A. Osipova
National Research University Belgorod State University (BelSU))
Russian Federation
Olga Alexandrovna Osipova - Department of hospital therapy, Professor of the Department
Russian Federation
Olga Alexandrovna Osipova - Department of hospital therapy, Professor of the Department
References
1. Ruzicka M, Ramsay T, Bugeja A, et al. Does pragmatically structured outpatient dietary counselling reduce sodium intake in hypertensive patients? Study protocol for a randomized controlled trial. Trials. 2015;16(1):1–7. doi:10.1186/s13063-015-0794-y.
2. Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: Meta-analysis on 376,162 patients. American Journal of Medicine. 2012;125(9):882-887. doi:10.1016/j.amjmed.2011.12.013.
3. Wei J, Hollin I, Kachnowski S. A review of the use of mobile phone text messaging in clinical and healthy behaviour interventions. Journal of Telemedicine and Telecare. 2011;17(1):41–48. doi:10.1258/jtt.2010.100322.
4. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension [published correction appears in J Hypertens. 2019 Jan;37(1):226]. J Hypertens. 2018;36(10):1953-2041. doi:10.1097/HJH.0000000000001940.
5. McManus RJ, Mant J, Franssen M, et al. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. Lancet. 2018;391(10124):949–959. doi:10.1016/S0140-6736(18)30309-X.
6. Alhaddad IA, Hamoui O, Hammoudeh A, et al. Treatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence. Vascular Health and Risk Management. 2016;12:407–413. doi:10.2147/VHRM.S105921.
7. Scott Leslie R, Gilmer T, Natarajan L, et al. A multichannel medication adherence intervention influences patient and prescriber behavior. Journal of Managed Care and Specialty Pharmacy. 2016;22(5):526–538. doi:10.18553/jmcp.2016.22.5.526.
8. Jung O, Gechter JL, Wunder C. et al. Resistant hypertension? Assessment of adherence by toxicological urine analysis. Journal of Hypertension. 2013;31:766–774. doi:10.1097/HJH.0b013e32835e2286.
9. McManus RJ, Mant J, Haque MS, et al. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: The TASMIN-SR randomized clinical trial. JAMA. 2014;312(8):799–808. doi:10.1001/jama.2014.10057.
10. Eisenberger U, Wüthrich RP, Bock A, et al. Medication adherence assessment: High accuracy of the new ingestible sensor system in kidney transplants. Transplantation. 2013;96(3):245–50. doi:10.1097/TP.0b013e31829b7571.
11. Verberk WJ, Kessels AGH, Thien T. Telecare is a valuable tool for hypertension management, a systematic review and meta-analysis. Blood Pressure Monitoring. 2011;16(3):149–155. doi:10.1097/MBP.0b013e328346e092.
12. Tomaszewski M, White C, Patel P, et al. High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis. Heart. 2014;100(11):855–861. doi:10.1136/heartjnl-2013-305063.
13. Abughosh S, Wang X, Serna O, et al. A Pharmacist Telephone Intervention to Identify Adherence Barriers Hypertension and Diabetes in a Medicare Advantage Plan. Journal of Managed Care and Specialty Pharmacy. 2016;22(1):63–73.
14. Schroeder K, Fahey T, Ebrahim S. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database Syst Rev. 2004;(2):CD004804. doi:10.1002/14651858.CD004804.
15. Widmer RJ, Collins NM, Collins CS, et al. Digital health interventions for the prevention of cardiovascular disease: A systematic review and meta-analysis. Mayo Clinic Proceedings. 2015;90(4):469–480. doi:10.1016/j.mayocp.2014.12.026.
16. Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: Meta-analysis on 376,162 patients. American Journal of Medicine. 2012;125(9):882-887. doi:10.1016/j.amjmed.2011.12.013.
17. Wei J, Hollin I, Kachnowski S. A review of the use of mobile phone text messaging in clinical and healthy behaviour interventions. Journal of Telemedicine and Telecare. 2011;17(1):41–48. doi:10.1258/jtt.2010.100322.
18. Ruzicka M, Ramsay T, Bugeja A, et al. Does pragmatically structured outpatient dietary counselling reduce sodium intake in hypertensive patients? Study protocol for a randomized controlled trial. Trials. 2015;16(1):1–7. doi:10.1186/s13063-015-0794-y.
19. Osterberg L, Blaschke T. Adherence to Medication. New England Journal of Medicine. 2005;353(5):487–497. doi:10.1056/NEJMra050100.
20. Alhaddad IA, Hamoui O, Hammoudeh A, et al. Treatment adherence and quality of life in patients on antihypertensive medications in a Middle Eastern population: adherence. Vascular Health and Risk Management. 2016;12:407–413. doi:10.2147/VHRM.S105921.
21. Scott Leslie R, Gilmer T, Natarajan L, et al. A multichannel medication adherence intervention influences patient and prescriber behavior. Journal of Managed Care and Specialty Pharmacy. 2016;22(5):526–538. doi:10.18553/jmcp.2016.22.5.526.
22. McManus RJ, Mant J, Franssen M, et al. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. Lancet. 2018;391(10124):949–959. doi:10.1016/S0140-6736(18)30309-X.
23. Haskard Zolnierek KB, DiMatteo MR. Physician Communication and Patient Adherence to Treatment. Medical Care. 2009;47(8):826–834. doi:10.1097/MLR.0b013e31819a5acc.
24. Eisenberger U, Wüthrich RP, Bock A, et al. Medication adherence assessment: High accuracy of the new ingestible sensor system in kidney transplants. Transplantation. 2013;96(3):245–50. doi:10.1097/TP.0b013e31829b7571.
25. Verberk WJ, Kessels AGH, Thien T. Telecare is a valuable tool for hypertension management, a systematic review and meta-analysis. Blood Pressure Monitoring. 2011;16(3):149–155. doi:10.1097/MBP.0b013e328346e092.
26. McManus RJ, Mant J, Haque MS, et al. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: The TASMIN-SR randomized clinical trial. JAMA. 2014;312(8):799–808. doi:10.1001/jama.2014.10057.
27. Lauffenburger JC, Landon JE, Fischer MA. Effect of Combination Therapy on Adherence Among US Patients Initiating Therapy for Hypertension: a Cohort Study. Journal of General Internal Medicine. 2017;32(6):619–625. doi:10.1007/s11606-016-3972-z.
28. Schroeder K, Fahey T, Ebrahim S. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database Syst Rev. 2004;(2):CD004804. doi:10.1002/14651858.CD004804.
29. Widmer RJ, Collins NM, Collins CS, et al. Digital health interventions for the prevention of cardiovascular disease: A systematic review and meta-analysis. Mayo Clinic Proceedings. 2015;90(4):469–480. doi:10.1016/j.mayocp.2014.12.026.
30. Abughosh S, Wang X, Serna O, et al. A Pharmacist Telephone Intervention to Identify Adherence Barriers Hypertension and Diabetes in a Medicare Advantage Plan. Journal of Managed Care and Specialty Pharmacy. 2016;22(1):63–73.
31. Iyengar RN, LeFrancois AL, Henderson RR, et al. Medication nonadherence among medicare beneficiaries with comorbid chronic conditions: Influence of pharmacy dispensing Channel. Journal of Managed Care and Specialty Pharmacy. 2016;22(5):550–560. doi:10.18553/jmcp.2016.22.5.550.
32. Ruzicka M, Ramsay T, Bugeja A, et al. Does pragmatically structured outpatient dietary counselling reduce sodium intake in hypertensive patients? Study protocol for a randomized controlled trial. Trials. 2015;16(1):1–7. doi:10.1186/s13063-015-0794-y.
33. Osterberg L, Blaschke T. Adherence to Medication. New England Journal of Medicine. 2005;353(5):487–497. doi:10.1056/NEJMra050100.
34. Wei J, Hollin I, Kachnowski S. A review of the use of mobile phone text messaging in clinical and healthy behaviour interventions. Journal of Telemedicine and Telecare. 2011;17(1):41–48. doi:10.1258/jtt.2010.100322.
35. Fanelli D. Negative results are disappearing from most disciplines and countries. Scientometrics. 2012;90(3):891–904. doi:10.1007/s11192-011-0494-7.
36. McManus RJ, Mant J, Franssen M, et al. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. Lancet. 2018;391(10124):949–959. doi:10.1016/S0140-6736(18)30309-X.
37. Haskard Zolnierek KB, DiMatteo MR. Physician Communication and Patient Adherence to Treatment. Medical Care. 2009;47(8):826–834. doi:10.1097/MLR.0b013e31819a5acc.
38. Scott Leslie R, Gilmer T, Natarajan L, et al. A multichannel medication adherence intervention influences patient and prescriber behavior. Journal of Managed Care and Specialty Pharmacy. 2016;22(5):526–538. doi:10.18553/jmcp.2016.22.5.526.
39. Lauffenburger JC, Landon JE, Fischer MA. Effect of Combination Therapy on Adherence Among US Patients Initiating Therapy for Hypertension: a Cohort Study. Journal of General Internal Medicine. 2017;32(6):619–625. doi:10.1007/s11606-016-3972-z.
40. McManus RJ, Mant J, Haque MS, et al. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: The TASMIN-SR randomized clinical trial. JAMA. 2014;312(8):799–808. doi:10.1001/jama.2014.10057.
41. Iyengar RN, LeFrancois AL, Henderson RR, et al. Medication nonadherence among medicare beneficiaries with comorbid chronic conditions: Influence of pharmacy dispensing Channel. Journal of Managed Care and Specialty Pharmacy. 2016;22(5):550–560. doi:10.18553/jmcp.2016.22.5.550.
42. Verberk WJ, Kessels AGH, Thien T. Telecare is a valuable tool for hypertension management, a systematic review and meta-analysis. Blood Pressure Monitoring. 2011;16(3):149–155. doi:10.1097/MBP.0b013e328346e092.
43. Fanelli D. Negative results are disappearing from most disciplines and countries. Scientometrics. 2012;90(3):891–904. doi:10.1007/s11192-011-0494-7.
44. Abughosh S, Wang X, Serna O, et al. A Pharmacist Telephone Intervention to Identify Adherence Barriers Hypertension and Diabetes in a Medicare Advantage Plan. Journal of Managed Care and Specialty Pharmacy. 2016;22(1):63–73.
45. Widmer RJ, Collins NM, Collins CS, et al. Digital health interventions for the prevention of cardiovascular disease: A systematic review and meta-analysis. Mayo Clinic Proceedings. 2015;90(4):469–480. doi:10.1016/j.mayocp.2014.12.026.
46. Wei J, Hollin I, Kachnowski S. A review of the use of mobile phone text messaging in clinical and healthy behaviour interventions. Journal of Telemedicine and Telecare. 2011;17(1):41–48. doi:10.1258/jtt.2010.100322.
47. Osterberg L, Blaschke T. Adherence to Medication. New England Journal of Medicine. 2005;353(5):487–497. doi:10.1056/NEJMra050100.
48. Scott Leslie R, Gilmer T, Natarajan L, et al. A multichannel medication adherence intervention influences patient and prescriber behavior. Journal of Managed Care and Specialty Pharmacy. 2016;22(5):526–538. doi:10.18553/jmcp.2016.22.5.526.
49. Haskard Zolnierek KB, DiMatteo MR. Physician Communication and Patient Adherence to Treatment. Medical Care. 2009;47(8):826–834. doi:10.1097/MLR.0b013e31819a5acc.
50. Verberk WJ, Kessels AGH, Thien T. Telecare is a valuable tool for hypertension management, a systematic review and meta-analysis. Blood Pressure Monitoring. 2011;16(3):149–155. doi:10.1097/MBP.0b013e328346e092.
51. Lauffenburger JC, Landon JE, Fischer MA. Effect of Combination Therapy on Adherence Among US Patients Initiating Therapy for Hypertension: a Cohort Study. Journal of General Internal Medicine. 2017;32(6):619–625. doi:10.1007/s11606-016-3972-z.
52. Widmer RJ, Collins NM, Collins CS, et al. Digital health interventions for the prevention of cardiovascular disease: A systematic review and meta-analysis. Mayo Clinic Proceedings. 2015;90(4):469–480. doi:10.1016/j.mayocp.2014.12.026.
53. Iyengar RN, LeFrancois AL, Henderson RR, et al. Medication nonadherence among medicare beneficiaries with comorbid chronic conditions: Influence of pharmacy dispensing Channel. Journal of Managed Care and Specialty Pharmacy. 2016;22(5):550–560. doi:10.18553/jmcp.2016.22.5.550.
54. Osterberg L, Blaschke T. Adherence to Medication. New England Journal of Medicine. 2005;353(5):487–497. doi:10.1056/NEJMra050100.
55. Fanelli D. Negative results are disappearing from most disciplines and countries. Scientometrics. 2012;90(3):891–904. doi:10.1007/s11192-011-0494-7.
56. Haskard Zolnierek KB, DiMatteo MR. Physician Communication and Patient Adherence to Treatment. Medical Care. 2009;47(8):826–834. doi:10.1097/MLR.0b013e31819a5acc.
57. Lauffenburger JC, Landon JE, Fischer MA. Effect of Combination Therapy on Adherence Among US Patients Initiating Therapy for Hypertension: a Cohort Study. Journal of General Internal Medicine. 2017;32(6):619–625. doi:10.1007/s11606-016-3972-z.
58. Iyengar RN, LeFrancois AL, Henderson RR, et al. Medication nonadherence among medicare beneficiaries with comorbid chronic conditions: Influence of pharmacy dispensing Channel. Journal of Managed Care and Specialty Pharmacy. 2016;22(5):550–560. doi:10.18553/jmcp.2016.22.5.550.
59. Fanelli D. Negative results are disappearing from most disciplines and countries. Scientometrics. 2012;90(3):891–904. doi:10.1007/s11192-011-0494-7.
Review
For citations:
Bunova S.S., Zhernakova N.I., Fedorin M.M., Skirdenko Y.P., Osipova O.A. Effective antihypertensive therapy: focus on adherence management. Cardiovascular Therapy and Prevention. 2020;19(5):2663. (In Russ.) https://doi.org/10.15829/1728-8800-2020-2663
Views:
777
Email this article 
